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ABSTRACT:  
Cardiovascular disease (CVD) is a leading cause of mortality and morbidity in developed 
countries. CVD is initiated by atherosclerotic lesions that reduce arterial lumen size through 
plaque formation and decreasing blood flow to the heart and frequently leading to severe 
complications. To cure these diseases drug delivery technologies modify drug release profile, 
absorption and distribution for the benefit of improving product efficacy and safety. 
Nano-medicine is an expeditiously growing science in which nanoscale range materials are 
used to serve the purpose of therapeutic agents. Among all the other interesting applications of 
nanomaterials, the nano-drug delivery system has emerged as an outstanding platform to 
deliver the remedial agents to a diseased site in a more controlled and targeted manner. By site-
specificity, lowering toxicity and target-oriented delivery, nanotechnology endeavours many 
benefits by treating frightful diseases. The current review examines nano-drug delivery 
systems, nanoparticles and describes recent computational simulations of magnetic targeted 
nano-pharmacodynamics. 
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1. Introduction 
In the recent past quite a good number of theoretical and experimental investigations related to 
blood flow in arteries in the presence of stenosis have been carried out with various 
perspectives in the area of arterial biomechanics depending upon the objectivity of the 
problems of the life sciences. Human blood is a heterogeneous multiphase suspension of blood 
cells (red blood, white blood, platelets) in plasma, which constitutes about 55% of total blood 
volume and is composed of mostly water, dissipated proteins, mineral ions, clotting factors, 
hormones and blood cells [1]. It has been pointed out that the plasma behaves as a Newtonian 
fluid; however, whole blood exhibits non-Newtonian fluid nature [2]. For shear rate larger than 
100 s-1, blood exhibits a Newtonian nature, and this arises in for example, large arteries, veins 
and in large cavities. However, for shear rate less than 100 s-1, blood behaviour is non-
Newtonian i.e. hemo-rheological. Blood cell and plasma characteristics are presented in Table 
1 and Table 2. Blood vessels are one of the important components of the circulatory system. 
Vessels are mainly divided into capillaries, veins and arteries, in which veins are responsible 
for carrying deoxygenated blood towards the heart whereas arteries carry oxygenated blood 
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from the heart to various parts of the body. Generally, capillaries are of size about 5-10 mm in 
diameter and veins ranges between 1 mm to 1-1.5 cm in diameter. In the case of arteries, elastic 
artery diameter is always greater than 1 cm and for muscular arteries, it is about 0.1-10 mm. 
 
 
Blood component Per microliter Size (µm) Percentage 
Red blood cell 4.1-5.1 x 106 7-8 97 
White blood cell       Neutrophils 
(4-10 x 103)             Lymphocytes 
                                 Eosinophils 
                                 Monocytes 
                                 Basophils 
62% of WBC 
30% of WBC 
2.3% of WBC 
5.3% of WBC 
0.4% of WBC 
10-12 
6-14 
- 
15-20 
- 
2 
Platelet 1.5-4.5 x 105 3 1 
Table 1: Blood Cell Characteristics [1] 
 
The thermophysical properties of blood, for example, viscosity, density etc are shown in Table 
3. It is seen that different parameters such as temperature, age and hematocrit influence the 
thermophysical properties of blood. The blood vessels bifurcate at frequent intervals and the 
diameter of the vessels varies with the distance as propounded by Whitmore [1] in 1968. The 
concept of flow in a varying cross-section forms the prime basis of a large class of problems in 
understanding blood flows as noted by Manton [3]. The accurate reason for formulation of 
stenosis is not known, but its influence over the flow characteristics has been considered 
theoretically and experimentally by many researchers. Accordingly, numerous investigations 
have discussed the blood flow characteristics (such as blood velocity, pressure and shear stress) 
to understand their role in the formation of stenosis and the validity of treatments [4]. A large 
number of studies have been carried out to elaborate the blood flow circulation in arteries. 
Plasma 
Component 
Component 
 
Molecular 
weight 
Density 
(g/dl) 
Plasma             Water 91% 
                Protein 7% 
 
Albumin   
Fibrinogen   
Immunoglobulins  
Prothrombin  
 
69000 
340000 
140000 
68700  
 
4.5 
0.3 
2.5 
0.015 
Other              Salt includes 
                       vitamin, lipid, 
                       sugar etc. 
   
Table 2: Plasma characteristics [1] 
 
2. Cardiovascular Diseases 
Hemodynamics has an integral role in the formation and evolution of cardiovascular diseases. 
Accumulation of macrophage white blood cells, low-density lipoproteins (LDL) and deposition 
of cholesterol to the arterial wall of blood vessels results in a hardening of the arteries and 
reduction in the cross-sectional area of the blood vessel thereby leading to cardiovascular 
diseases. Many diseases affect the circulatory system. These include a number 
of cardiovascular diseases such as Atherosclerosis, Aneurysms, Stroke, Angina etc. affecting 
the cardiovascular system, and lymphatic diseases affecting the lymphatic system. Many of 
these diseases are called "lifestyle diseases" because they develop over time and are related to 
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a person's exercise habits, diet, whether they smoke, and other lifestyle choices a person 
makes.  
Across a wide range of cardiovascular diseases, the best outcome depends on the ability to 
successfully direct drugs towards a specific diseased zone. Despite intense research and 
developments in drug delivery, present-day pharmacological formulations still leave the drug 
incapable of precisely localizing en mass at sites of interest. The drug molecules diffuse and 
spread in many cases randomly throughout the body, resulting in undesirable side effects and 
a reduction in the active response of proper doses. In recent years a new branch of fluid 
dynamics, focused on engineering fluids at the nanoscale, has emerged - nanofluid dynamics. 
Nanofluids have had a significant impact in improving miscellaneous applications in energy 
systems, industrial processes, transport, environmental and biomedical sciences. 
 
Figure 1: A normal artery versus diseased artery [5] 
3. Clinical Importance 
According to World Health Organization (WHO) report 2019 [6], CVDs are the number 1 
cause of death globally: more people die annually from CVDs than from any other cause. An 
estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. 
Of these deaths, 85% are due to heart attack and stroke. Over three quarters of CVD deaths 
take place in low- and middle-income countries. Out of the 17 million premature deaths (under 
the age of 70) due to non-communicable diseases in 2015, 82% are in low- and middle-income 
countries, and 37% are caused by CVDs. Most cardiovascular diseases can be prevented by 
addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical 
inactivity and harmful use of alcohol using population-wide strategies. In 2016, cardiovascular 
diseases contributed 28.1% of the total deaths in India. For CVDs, the dominating risk factors 
include high systolic blood pressure, air pollution, high cholesterol, dietary risks, tobacco use 
and high body mass index.   
 
4. Nanofluids and Applications 
Conventional fluids (air, water, oils etc) in industrial applications exhibit excellent lubrication 
properties; however, they have poor thermal characteristics which severely restrain their use. 
Nowadays, many researchers have been focused on developing techniques to increase heat 
transfer rates of conventional fluids. Experimentally it was found that the addition of small-
sized solid particles in the base fluid can greatly enhance the thermo-physical properties.  
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In 1995, Choi [7] coined a new term “nanofluid”, which 
is defined as a colloidal suspension of nanometer-sized 
particles (1-100nm) in a base fluid. These nanoparticles 
can be oxide, carbide, metallic, non-metallic, carbonic, 
hybrid and even more liquid droplets. The base fluid 
includes water, mineral oil, ethylene glycol or 
refrigerants. Both theoretical and experimental studies, 
largely based on the Buongiorno model [8] which is a 
two-component nanoscale formulation emphasizing 
Brownian motion and thermophoretic body force 
effects (originating in nuclear engineering at MIT) or 
the Tiwari-Das model [9] which is a volume-fraction-
based doping model. It has been shown that the 
inclusion of nanoparticles (termed “doping”) in base fluids increases the thermal conductivity 
remarkably and this contributes principally to the improved thermal performance of nanofluids 
[10]. The nanoparticles employed in biomedicine are also synthetic due to their unique 
interaction with biological matter [11, 12]. Generally, the rate of heat exchange in thermal 
systems is enhanced by using a nanofluid, due to the superior thermal conductivity over the 
conventional fluid. Therefore, by using nanofluids to enhance the heat transfer rate, the size of 
a thermal system can be optimized by transferring a specific value of heat which makes the 
system more compact. Relative to microfluids, nanofluids possess a higher stability and better 
potential to increase the heat conduction. In many heating and cooling applications, nanofluids 
are superseding conventional fluids. Nanofluids can be used in car radiators, boilers, cooling 
of electronic equipment, solar collector systems, refrigerators, pharmacological drug delivery, 
sterilization, fuel cells, lubrication of components, aerospace coatings and fuels, enhanced oil 
recovery techniques and liquid based heat exchangers. Figure 2 gives an overview of different 
applications of nanofluids. 
 
5. Drug Delivery Systems 
A drug delivery system (DDS) is defined as a formulation or a device that enables the 
introduction of a therapeutic substance into the body and improves its efficacy and safety by 
controlling the rate, time, and place of release of drugs in the body. Drug delivery [13] 
technologies modify drug release profile, absorption, distribution and elimination for the 
benefit of improving product efficacy and safety, as well as patient convenience and 
compliance. Despite numerous research and development for drug delivery, present-day 
formulations still leave the drugs incompetent in localizing en mass at sites of interest. These 
drug molecules diffuse and spread randomly throughout the body, resulting in undesirable side 
effects and this reduces the active response of proper doses. In recent years a new branch of 
fluid dynamics has appeared, namely as nanofluid dynamics, which finds miscellaneous 
applications in energetics, medical science and biology. A very different application of 
nanofluids could be in modern medicine, where for example, nanodrugs are mixed in 
microchannels for controlled delivery with bio-MEMS (micro electro-mechanical system). For 
this purpose, nanoparticle- based drug delivery has immense potential for therapeutics having 
minimal side effects and optimizing specific targeted delivery. In spite of the potential of 
increasing a drug’s propensity to accumulate at a targeted sited, the platform also faces a 
complex series of biological barriers that limit site-specific bioavailability, preventing 
achievement of proper therapeutic outcomes. The nanoparticles (especially copper) have been 
widely used for treatment, diagnosis, medical device coating and in drug delivery areas. Types 
of nanoparticles used for clinical research are shown in figure 3. Mechanisms of clearing blot 
clots with nanoparticles are shown in fig. 4. Among the most attractive and powerful strategies 
Figure 2: Applications of Nanofluids  
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for pharmacological drug delivery in affected site is the magnetic targeted drug delivery system 
(MTDDS). In comparison with conventional methods, MTDDS are fast-acting and highly 
efficient and owing to their capacity in reducing toxicity and other adverse side effects, they 
are becoming more popular in biomedicine [14]. Biomedical applications of magnetic nano 
particles (MNPs) are classified according to their application: in vivo or in vitro. In vivo 
applications involve therapeutics and diagnostics while in vitro applications relate to diagnostic 
usage (seperation/selection). MNPs  are widely used in cell and macromolecule seperation, 
targeted drug delivery, electromagnetic hyperthermia, magnetic resonance imaging (MRI) and 
gene therapy. However the targeting properties of MNPs make them particularly appropriate 
for  drug delivery systems [15]. 
 
 
Figure 3 : Types of nanoparticles [15] 
 
Key characteristics of magnetic nanoparticles are that they can be: (a) projected in place by 
using of magnetic field (b) visualized (c) heated in the presence of magnetic field to generate 
drug release. The Food and Drug Administration (FDA) have approved the use of iron oxides 
(or particular, magnetite) and 
confirmed that they are totally safe 
for humans [16]. Nano-based drug 
delivery systems have great potential 
in the field of health care. They 
provide better penetration of drugs 
through the body as their size allows 
delivery via injection or other routes. 
The application of nanoscience in 
medicine aims to improve the existing 
treatment regarding these diseases. 
Nanotechnology provides an 
effective and safe platform in 
controlled drug delivery systems for a 
range of active ingredients, which are 
directed to lipid disorders, 
angiogenesis within atherosclerosis and inflammation and avoidance of thrombosis among 
other diseases. Iron oxide super-paramagnetic nanoparticles are a major development in the 
magnetic drug targeting [17]. The magnetic drug targeted system provides appropriate 
Figure 4: How nanoparticles clear the blood clot  
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magnetic gradients, which further increase the concentration of nanoparticles at the affected 
site [18].  
6. Computational Nano-Pharmacodynamics/Nano-Hemodynamics 
Many theoretical studies have been explored to illustrate the effect of various nanoparticles 
(drugs) in blood flows and this area of study is known as nano-pharmacodynamics or nano-
hemodynamics. In particular, stenotic nano-hemodynamics has witnessed considerable interest 
in the engineering sciences and applied mathematics communities owing to its significance in 
combatting diseased arteries. The many studies reported have also featured numerous 
computational methods which are required to tackle the nonlinearity of the mathematical 
models. Nadeem et al. [19] studied the steady blood flow through tapered stenosed arteries 
using nanoparticles with a Prandtl blood flow mode and a homotopy perturbation method. 
Ahmed et al. [20] investigated the influence of different   nanoparticles (Cu, TiO2, Al2O3) on 
Newtonian blood flow in a single stenosed vessel, noting that flow acceleration in the core 
region is greater for Al2O3 nanoparticles than either Cu or TiO2 nanoparticles. Ali et al. [21] 
performed a numerical simulation of time-dependent non-Newtonian (Sisko fluid) nano-
pharmacodynamic transport phenomenon in an overlapping tapered artery using Buongiorno’s 
model and a forward time central space (FTCS) method. Results were validated with finite 
element method (FEM) and it was found that flow rate at stenotic throat decreases with an 
increase in the Brownian motion parameter. Very recently, Vasu et al. [22] have developed a 
robust model of non-Newtonian nanofluid hemodynamics with heat and mass diffusion in a 
stenosed coronary artery in the presence of a radial magnetic field. We briefly describe some 
of the details of that simulation here to provide a deeper understanding of nano-drug diffusion 
in the treatment of cardiovascular disease (stenotic arteries). Buongiorno’s nanoscale model 
and the Reiner-Rivlin second order differential model are employed in the formulation. The 
geometry considered is reproduced in Fig. 5.  
 
Figure 5.  Schematic illustration of stenosed coronary arterial model [22] 
 
The FreeFEM++ finite element code [62] was used to compute hemodynamic characteristics 
in this study. The finite element mesh was designed with 5928 unstructured fixed triangular 
elements with 12177 nodes as presented in Figure 6. The mesh generation was accomplished 
with the automatic FreeFEM++ mesh generator based on the Delaunay-Voronoi algorithm.  
 
Radial magnetic 
field, Bo 
Metallic 
nanoparticle  
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Figure 6. Unstructured triangular fixed finite element mesh [22] 
 
Some selected simulations are shown in Figs. 7 (a) to (d) which depict the streamlines of blood 
flow for specific values of M and 
t
N   when
1
0.3, 0.5, 5 0.3
b
N A B and c= = = = = . In Fig 7(a), 
the presence of a circulating bolus of blood enclosed by the streamlines in the stenotic region 
of the artery represents that if the size of the bolus will be decreased, the flow acceleration will 
also be decreased at the stenotic part of the artery. The bigger the bolus the higher the 
acceleration at that point. It can be seen from the two figures 7(a) and 7(b), by applied magnetic 
field the strength of the circulating region reduced. However, comparing the 7(a) with 7(c), 
even with alteration in magnetic parameter (M) there seems no significant deviation in size and 
circulation of this bolus of blood. This indicates that the circulating bolus of blood is relatively 
insensitive to magnetic field. However, inspection of Figs. 7(b), 7(d), shows that there is some 
deviation in the characteristics (magnitude and structure) of the bolus of blood with a change 
in thermophoresis parameter. 
 
Figure 7 Streamlines of blood flow in the arterial segment when a)  0.3, 0.3
t
M N= =                               
b) 0.3, 0.6
t
M N= =  c)  0.6, 0.3
t
M N= =  d)  0.6, 0.6
t
M N= =  
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   8(a)                8(b) 
      
   8(c)      8(d)    
 Figure 8 Nanoparticle Concentration for (a)
1
0.5, 0.3, 0.3 0.3
b t
M N and N = − = = = , (b) 
1
0.5, 0.3, 0.3 0.6
b t
M N and N = − = = = , (c) 
1
0.5, 0.6, 0.3 0.3
b t
M N and N = − = = =  (d)  
1
0.5, 0.6, 0.3 0.6
b t
M N and N = − = = = . 
 
Figures 8(a) - (d) visualize the nanoparticle concentration contours for various magnetic body 
force parameters (M) and thermophoresis parameters (
t
N ) with fixed values of Brownian 
motion parameter ( bN  =0.3) and viscoelastic parameter (1= -0.5). Comparing fig. 8a with 8d 
the thermophoresis parameter is increased from 0.3 to 0.6 with all other parameters constrained, 
there is an expansion in the orange (lower magnitude contour) zone is expanded and the 
engulfing yellow zone (higher magnitude contour) is contracted. The values for nano-particle 
concentration are therefore reduced along the axial direction and radial direction in the vicinity 
of the stenotic region. Species diffusion of nanoparticles into the core region is therefore 
decreased with greater thermophoretic effect. Comparing fig. 8a with fig. 8c, the magnetic 
parameter is increased from M = 0.3 to 0.6, with all other parameters fixed. A similar response 
to the thermophoretic effect is observed i.e. the orange zone is expanded and the yellow zone 
is diminished Stronger magnetic field therefore also inhibits nano-particle diffusion into the 
core zone and results in decreasing magnitudes of nano-particle concentration along the entire 
arterial section i.e. with all axial coordinate locations.  Comparing fig. 8c and 8d this trend is 
further amplified with the emergence of a thin brown zone along the arterial mid-line indicating 
an even greater depletion in nano-particle concentration values. The combination of maximum 
magnetic parameter value and maximum thermophoresis parameter value therefore serves to 
strongly diminish nano-particle concentration values. The opposite effect i.e. elevation in nano-
particle diffusion may therefore be induced by utilizing a weaker magnetic field and lower 
thermophoresis in nano-particle deployment in stenotic blood flows. Computational nano-
hemodynamics clearly is a powerful tool for visualization in modern nano-biomedicine and 
drug delivery systems and provides an excellent methodology for optimizing the impact of 
different nano-drugs in clinical treatments. Other numerical methodologies are also very 
promising in this regard and include Lattice Boltzmann [23], molecular dynamics [24], 
smoothed particle hydrodynamics [25] and boundary element methods [26].  
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Conclusions 
In the present review, recent advances in nanomedicine have been considered in addition to 
progress in the delivery of old drugs with new therapeutic methods. Initially, to enhance the 
solubility, bioavailability, absorption and targeted and controlled release of drugs is the main 
motivation for implementing nanotechnology in biomedicine. The use of nano- carriers formulated 
with dendrimers, liposomes, micelles, solid lipid nanoparticles, gold, silver, titanium oxide and 
cadmium sulphide polymeric nanoparticles together with superparamagnetic iron oxide 
nanoparticles has been shown to substantially improve the efficacy of conventional 
pharmacological agents. Magnetic drug delivery systems also offer excellent potential due to their 
unique properties which are ideal for targeted and controlled delivery. This review has also 
described significant progress in the use of mathematical and computational hemodynamic models 
for simulating nanoparticle drug delivery effects in cardiovascular diseases (stenotic arteries, 
aneurysms etc). Computational nano-pharmaco/hemo-dynamics offers great advantages in 
providing deeper insight into the inherent mechanisms involved in nano-drug delivery. Many 
methods have been developed in this regard and warrant further investigation and corroboration 
with clinical findings. The advancement in nano-biomedicine along with improved safety and 
reduced toxicity will be greatly accelerated with computational modelling techniques. 
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